FOSLEVODOPA + FOSCARBIDOPA
foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials
FOSLEVODOPA + FOSCARBIDOPA (14876Y)
14876Y
Body System:
Manner of administration:Injection
Restriction 16951
Indication: Advanced Parkinson disease
Treatment phase: Maintenance therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 8 | Max qty units: 56 | # of repeats: 5 | DPMQ: $10,116.32 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Vyalev | |||||